🇺🇸

US SEC Filing Intelligence

· daily

Dow Jones 30 Stocks SEC Filings — September 02, 2026

This batch of Dow 30 filings reveals a bifurcated market where strong operational performance from Cisco (12% revenue growth, 30% net income surge) is contrasted by a marked acceleration of insider selling among mega-cap tech leaders, including CEO Satya Nadella of Microsoft ($16.5M sale) and a $98.5M block sale by an NVIDIA director. Period-over-period data paints a nuanced picture: while Cisco shows robust topline growth, margin compression of 40 bps and a doubling of inventories signal potential demand normalization. The most critical development is the high-conviction insider selling across Visa, Microsoft, Walmart, and NVIDIA, which collectively suggests management teams are capitalizing on elevated valuations, creating a tactical headwind for the tech-heavy Dow. Overall, the cohort shows strong historical earnings power but forward caution, with capital being returned to shareholders via buybacks while insiders trim exposure.

6 high priority 1 medium 7 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 02, 2026

The six filings paint a stark picture of corporate distress concentrated in the small-cap and micro-cap space, with three companies facing imminent Nasdaq delisting (Triller, IRIDEX, Reborn Coffee) and one (TScan Therapeutics) executing a drastic restructuring to avoid a cash crunch. A common theme is severe capital constraints forcing strategic pivots or asset sales, as seen in TScan's 75% workforce reduction and Twinlab's assignment for the benefit of creditors. Period-over-period data is limited in these event-driven filings, but the aggregate signals point to a sector-wide liquidity crisis among undercapitalized life sciences and consumer companies. The most actionable intelligence lies in the divergence between companies with viable turnaround plans (TScan, cbdMD/Twinlab) and those with unresolved compliance issues (Triller, Reborn Coffee). Insider activity is notably absent across all filings, suggesting management teams are either constrained or lacking conviction. The forward-looking catalyst calendar is dominated by Nasdaq compliance deadlines and IND filings, creating a binary event-driven trading environment.

6 high priority 6 total filings
· daily

Global High-Priority Regulatory Events — September 02, 2026

This digest covers 48 filings from September 2, 2026, dominated by corporate distress signals (insolvencies, delistings, asset sales) and deal-making (M&A, SPAC activity, open offers). A key theme is the high failure rate of SPACs, with Quantumsphere Acquisition Corp terminating its merger and significant redemptions at D. Boral ARC Merger Corp (96% of public shares redeemed). The Indian market shows a surge in insolvency filings (Parsvnath, Astron Paper, Baron Infotech) and a notable failed open offer for Bliss GVS Pharma, where only 0.00% of the target shares were tendered. Conversely, there is active capital deployment in renewable energy (India Cements) and specialty chemicals (Fine Organic Industries), alongside several new SPAC IPOs raising over $395 million. The data reveals a bifurcated market: distressed entities are liquidating or restructuring, while well-capitalized firms pursue strategic acquisitions and growth investments.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — September 02, 2026

Today's digest (Sept 2, 2026) reveals a market bifurcated between aggressive growth investments and defensive capital returns. The standout theme is a massive, coordinated equity award to TSMC's top management, signaling strong retention and confidence in future execution, while Sea Ltd's C-suite selling under 10b5-1 plans provides a contrasting note of caution. In the SPAC and small-cap space, deal risk is elevated, with Quantumsphere's merger termination and Nuburu's 1-for-40 reverse split highlighting distress. On the positive side, Bitdeer's $100M land acquisition for AI/HPC infrastructure and GitLab's 21% revenue growth (despite widening losses) show capital being deployed for long-term growth. Capital returns are steady, with Vertiv declaring a dividend and News Corp continuing its $1B buyback. The overall picture is one of selective opportunity, with a clear preference for companies with strong secular tailwinds (AI, cloud, semiconductors) over those with uncertain deal outcomes or dilutive financing structures.

29 high priority 21 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — September 02, 2026

Among the four filings, a mixed picture emerges for the S&P 500 Consumer Discretionary sector on September 2, 2026. Lowe's stands out positively with a strategic executive reshuffle designed to accelerate its 'Total Home' strategy, signaling a proactive push into the Pro and Home Services segments, which could drive a new growth cycle. Conversely, a director at Booking Holdings sold shares under a 10b5-1 plan, creating a modest but notable bearish signal in the travel space. Insider activity at Ulta Beauty and Las Vegas Sands is benign, representing routine compensation awards and a large charitable gift by a 10% owner, respectively. While period-over-period financial data is absent from these filings, the portfolio-level focus reveals two distinct trends: corporate reinvestment in operational capabilities (Lowe's) versus insider de-risking (Booking), suggesting a cautious optimism among management teams. The key actionable insight is that the market may be underappreciating Lowe's long-term strategic focus, while the Booking insider sale warrants monitoring for potential follow-through selling.

4 high priority 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 02, 2026

The three S&P 500 Healthcare filings reveal a sector with divergent insider sentiment: while Stryker's director is aggressively accumulating shares at an average cost of ~$199, signaling strong board-level conviction, Gilead's CEO is executing a large pre-planned sale of nearly $1.2M, which, though under a 10b5-1 plan, creates a notable contrast. Zoetis's CFO received a substantial restricted stock grant of 81,063 units, aligning long-term incentives with shareholder value. No period-over-period comparisons, forward-looking guidance, or capital allocation data were available in these filings, limiting trend analysis. The key portfolio-level pattern is the absence of any negative insider selling outside of Gilead's scheduled plan, suggesting overall management confidence remains intact. The most critical development is Stryker's insider buying at a low of $193.21, which may indicate the stock is undervalued relative to the director's perception. These filings collectively point to a healthcare sector where insider actions are mixed but not alarming, with Stryker offering the clearest bullish signal.

3 high priority 3 total filings
· daily

US Earnings Financial Results SEC Filings — September 02, 2026

The 19 filings for the period ending September 2, 2026, reveal a bifurcated market: high-growth tech and industrial companies (Keysight, Credo, Argan) are delivering exceptional revenue growth (36-115% YoY), while consumer-facing and legacy tech firms (PVH, Cisco) show signs of strain with impairments and margin compression. A notable theme is the aggressive use of cash for M&A and buybacks, which is depleting balance sheets at Credo, Ollie's, and GitLab, raising liquidity concerns despite strong operational performance. Insider trading activity was sparse in the filings, but capital allocation decisions (e.g., PVH's $439M impairment, NetApp's restructuring) signal strategic pivots. The most actionable opportunities lie in companies with accelerating growth and improving margins (Argan, Keysight), while risks are concentrated in companies with widening losses and cash burn (Netskope, Methode Electronics). The SPACs (Southern Cross, B&R Technology) and micro-cap MYX Inc. remain speculative and are excluded from core analysis.

19 high priority 19 total filings
· daily

US Executive Compensation Proxy SEC Filings — September 02, 2026

The single filing in this stream, Byrna Technologies Inc.'s DEF 14A proxy statement, reveals a company in a significant governance and leadership transition. The most critical development is the appointment of Conn Davis as CEO on March 2, 2026, following a nationwide search, signaling a potential strategic pivot. The Board has also been refreshed with four new independent directors since the 2025 meeting, indicating a push for enhanced oversight. While the filing's sentiment is neutral and materiality moderate, the governance changes are the key takeaway for investors. The upcoming virtual annual meeting on September 25, 2026, will include a non-binding advisory vote on executive compensation, providing a near-term catalyst for shareholder sentiment. The lack of period-over-period financial data or insider trading activity in the enriched data limits trend analysis, but the leadership and board refresh are actionable governance signals.

1 high priority 1 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 02, 2026

The IPO pipeline is showing mixed signals with one high-quality IPO filing and two debt exchange registrations that provide limited direct equity market exposure. Accelevation Holdings Corp.'s S-1 filing for an IPO on Nasdaq under the symbol 'ACCV' is the standout event, representing a material new equity offering with a controlled company structure and tax advantages via an Up-C structure. The two Cheniere-related S-4 filings are purely technical exchange offers to satisfy registration rights obligations, not new capital raises, and thus have limited relevance to the IPO pipeline theme. No period-over-period comparisons, insider trading activity, forward-looking guidance, or capital allocation data were available in the enriched data for any of the three filings, limiting the depth of quantitative trend analysis. The key actionable insight is the upcoming Accelevation IPO, which warrants close monitoring for pricing, valuation, and post-listing performance. The Cheniere filings serve as a reminder that registration statements can serve non-equity purposes and should be filtered carefully in an IPO-focused digest.

3 high priority 3 total filings
· daily

US SEC Trading Suspension Halt Orders — September 02, 2026

The five filings from September 2, 2026, reveal a severe cluster of Nasdaq non-compliance events, with three companies (IRIDEX, Triller Group, Reborn Coffee) receiving deficiency notices on the same day, August 27, 2026, signaling a potential tightening of exchange standards or a broader market downturn affecting small-cap stocks. TScan Therapeutics' strategic reorganization, involving a 75% workforce reduction and a pause in its Phase 3 study, underscores acute capital constraints in the biotech sector, while TEN Holdings' quick resolution of a governance issue stands as a rare positive. Period-over-period data from TScan shows a shift from heme to solid tumor focus, with a 100% success rate in a key biomarker (13/13 patients) but no revenue growth to offset cash burn. Insider activity is absent across all filings, limiting conviction signals. The dominant theme is regulatory risk from non-compliance, with three companies facing potential delisting, creating a high-risk environment for investors in micro-cap and pre-revenue stocks.

5 high priority 5 total filings
· daily

US Executive Officer Management Changes SEC — September 02, 2026

The September 2, 2026, digest of 31 filings reveals a significant wave of leadership transitions across US-listed companies, with a notable concentration of CFO changes (Hershey, NPK International, American Healthcare REIT, Allogene Therapeutics) and CEO departures (Acro Biomedical, Reliability Inc., authID, Definitive Healthcare). While most transitions are described as planned or mutual, several carry heightened materiality due to going-concern qualifications (BioRestorative Therapies, authID), conditional resignations tied to governance disputes (Better Home & Finance), or dramatic stock option repricing reflecting severe share price declines (Cloudastructure). The Lowe's executive appointments stand out as a positive, strategic reorganization to drive growth. Overall, the digest points to a period of corporate restructuring and succession planning, with a few high-risk situations requiring immediate investor attention. No period-over-period financial trends (revenue growth, margin compression) are available as the filings are event-driven 8-Ks without financial statements.

31 high priority 31 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — September 02, 2026

The sole filing in this session involves Twinlab Consolidated Holdings, Inc., which is undergoing an Assignment for the Benefit of Creditors (ABC) proceeding—a common alternative to Chapter 11 bankruptcy. cbdMD, Inc. has entered a definitive asset purchase agreement to acquire Twinlab's operating assets and brands, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The transaction is expected to boost cbdMD's trailing twelve-month revenue to approximately $30 million, a 40% increase over its standalone revenue, though this figure is illustrative and not guaranteed. The deal is subject to court approval, reflecting the insolvency-driven nature of the sale. No period-over-period comparisons, insider activity, or forward-looking guidance were provided in the filing, limiting trend analysis. The mixed sentiment stems from the strategic opportunity for cbdMD versus the underlying distress of Twinlab. This is a quiet session with no other bankruptcy or insolvency filings, making this the sole actionable event.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 02, 2026

The 31 filings reveal a significant wave of leadership transitions across US public companies, with a notable concentration of CFO and C-suite departures in the small-cap and micro-cap space. While the majority of changes are routine retirements or planned transitions, several filings carry heightened materiality due to governance instability, going-concern qualifications, and performance-linked compensation tied to a potential sale. A key theme is the 'revolving door' of interim leadership in cash-constrained companies, with BioRestorative, authID, and Advasa all experiencing simultaneous auditor or CFO changes. Conversely, large-cap firms like Lowe's and Hershey are executing strategic executive appointments to drive growth, signaling confidence in their forward strategies. The data also reveals a pattern of board refreshment, with Vail Resorts and AIG proactively managing board composition, while others like Better Home & Finance face conditional resignations that signal internal conflict. Overall, the digest points to a bifurcated market where established companies are strengthening their benches, while distressed entities are scrambling for stability.

31 high priority 31 total filings
· daily

USA Insider Trading Pulse — September 02, 2026

Today's insider trading pulse reveals a stark divergence: a massive $40M insider purchase by a 10% owner in AMG Pantheon Infrastructure Fund signals strong conviction in infrastructure assets, while multiple C-suite sales under 10b5-1 plans at Sea Ltd, Deere & Co, and Verizon suggest pre-planned but still notable profit-taking. The overwhelming theme is equity awards at Taiwan Semiconductor Manufacturing Co (TSMC), where 19 executives—including the Chairman/CEO—received shares totaling ~500K+ units, reinforcing a long-term alignment culture. On the sell side, a Deere & Co president cashed out ~$1.9M, and a Watts Water director sold $518K, both material. On the buy side, RGC Resources and Granite Ridge Resources saw director purchases at modest levels, signaling local confidence. Period-over-period trends are limited in this batch, but the absence of forward-looking guidance changes across filings is notable—most activity is transactional, not directional. The key takeaway: infrastructure and energy attract insider capital, while tech and industrials see planned liquidation.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 02, 2026

The US M&A landscape on September 2, 2026, is characterized by a surge in SPAC activity, with three new IPOs (Inflection Point, Southern Cross, JATT III) raising over $395M, alongside a notable de-SPAC completion (D. Boral ARC/Exascale) marred by massive redemptions (96% of public shares). Deal execution risk is elevated, evidenced by one merger termination (Quantumsphere), multiple deadline extensions (Lakeshore, Blue Acquisition), and a delisting notice (Eureka). Strategic divestitures are trending, with INNOVATE and FiscalNote shedding assets to focus on core operations, while G-III's Marc Jacobs acquisition highlights a pivot to owned brands amid a 10% sales decline. Negative signals dominate: SPAC warrant delisting risk (ARC Group), a foreclosure (Chase General), and high redemptions in completed deals. However, opportunities exist in G-III's margin expansion (440 bps) and ROC's strategic acquisition, while the settlement in EGH's litigation removes a key hurdle. Overall, the market shows a bifurcation between well-capitalized strategic buyers and struggling SPACs facing regulatory and shareholder pressure.

17 high priority 17 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 02, 2026

Overnight filings reveal a market bifurcated between aggressive insider buying at micro-cap biotech Quoin Pharmaceuticals and significant insider selling at high-growth industrials like Coherent and Standex, signaling divergent management conviction. The most material corporate event is the termination of the Quantumsphere Acquisition Corp. SPAC merger, a high-risk signal for the de-SPAC market. A notable sector theme is the concentrated insider buying in the biotech/pharma space, particularly at Quoin and Waste Energy, contrasting with routine insider selling for tax purposes at larger caps. Capital allocation is mixed, with Vertiv declaring a modest dividend while VolitionRx continues dilutive convertible note conversions. The Skyworks-Qorvo merger extension provides a key catalyst to monitor, while the HDFC Bank and ICICI Bank credit rating updates offer a positive signal for Indian financials. Overall, the data suggests a cautious market with selective, high-conviction bets in small-cap value and biotech, while large-cap tech and industrial insiders are reducing exposure.

34 high priority 16 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — September 01, 2026

The 14 filings from the S&P 500 Technology sector reveal a mixed picture: while Palo Alto Networks posted explosive 34% YoY revenue growth and a 63% surge in Next-Generation Security ARR, its GAAP net loss of $282M versus a prior-year profit signals heavy investment costs. Microsoft's top executives, including CEO Satya Nadella, engaged in routine tax-withholding stock transactions totaling over $68M, indicating no directional insider selling. Apple's new CEO compensation structure, with a $55M equity target for Ternus, underscores a leadership transition and a focus on long-term performance. Insider selling at ServiceNow and Lam Research, though small in scale, adds a cautious tone. The dominant theme is heavy capital allocation toward AI and security platforms, with Palo Alto's Console acquisition and Microsoft's large equity awards reinforcing this trend. Period-over-period data shows revenue acceleration at Palo Alto but margin compression, while insider activity at Microsoft is neutral and routine. The most critical development is Palo Alto's guidance for FY27 revenue of $14.1B-$14.2B (23-24% growth), which, combined with its NGS ARR trajectory, positions it as a key AI security beneficiary. Overall, the sector is bifurcated between high-growth AI leaders and mature players with stable insider patterns.

5 high priority 9 medium 14 total filings
· daily

Nasdaq 100 Stocks SEC Filings — September 01, 2026

This digest of 12 pre-analyzed NASDAQ-100 filings reveals a dominant theme of insider activity, particularly at Microsoft, where a wave of stock vesting and tax withholding transactions by top executives—including CEO Satya Nadella, CFO Amy Hood, and President Brad Smith—signals routine compensation events rather than directional trading, but underscores the magnitude of equity-linked wealth tied to the company's stock price. Apple's leadership transition filings formalize a massive $100M total equity award target for incoming CEO John Ternus in fiscal 2027, a bullish signal for management continuity and alignment with shareholder value. The two notable open-market insider sales at Lam Research and Booking Holdings, though moderate in materiality, add a cautious tint to those names. Strategy Inc's routine preferred dividend declaration, with a high 12% yield, highlights a capital allocation focus on aggressive leverage and bitcoin exposure. Across the period, no negative revenue or margin trends were reported, but the absence of forward-looking guidance changes and heavy algorithm-driven sales suggests limited near-term tactical signals beyond these compensation and routine events.

3 high priority 9 medium 12 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — September 01, 2026

The September 1, 2026 batch of 23 filings reveals a dominant theme of passive institutional positioning, with the most significant activist event being a decisive legal victory for ATG Capital against Empery Digital Inc., creating a high-conviction catalyst. A notable cluster of seven separate filings for Universe Pharmaceuticals INC reveals a fragmented ownership structure with multiple 9-10% passive holders, suggesting a potential hidden control structure or coordinated accumulation that warrants close monitoring. The OrthoPediatrics Corp filing shows a major activist (Squadron Capital) actively reducing its 25% stake to raise capital, creating a persistent overhang. Insider activity is minimal across the batch, with the most material signal being the complete exit of Advent International from NCS Multistage Holdings. The period-over-period data is limited in these initial ownership filings, but the transaction details and forward-looking legal catalysts provide actionable intelligence. The overall sentiment is neutral with one high-conviction mixed (bullish) signal from the Empery Digital court ruling. The key takeaway is that while most filings are passive, the Empery Digital situation and the Universe Pharmaceuticals ownership puzzle offer the most alpha generation potential.

4 high priority 19 medium 23 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 01, 2026

The 21 filings in the S&P 500 Financials stream center on a massive, coordinated transfer of CMBS special servicing rights from Greystone Servicing Company LLC to C-IV Asset Management LLC (C-IV AM), effective September 1, 2026, across 13 separate 8-K filings. This bulk transfer, involving roughly 60 securitization transactions and a $20.7 billion portfolio, is a routine administrative change with no material financial impact on any individual trust, but it highlights a key operational trend: the active special servicing portfolio has surged from $969 million (Dec 2023) to $2.1 billion (mid-2026), signaling rising distress in commercial real estate debt, especially office and retail collateral. Separately, insider selling by senior executives at Mastercard, Goldman Sachs, and Visa, along with a 10% owner at Aflac, all under Rule 10b5-1 plans, collectively shows a pattern of monetization but not alarm, though the dollar amounts ($548K–$1.51M) are moderate relative to total holdings. Capital One's routine preferred stock redemption is a minor capital structure cleanup. Period-over-period comparisons from the CMBS data show a 31% decline in the named portfolio from $30.0B (year-end 2024) to $20.7B (mid-2026), potentially due to loan payoffs, while active distressed assets more than doubled, a key divergence. Overall, the digest reveals a sector-wide administrative shakeup in CMBS servicing, a modest wave of insider selling across financial giants, and a growing distress signal in commercial real estate that warrants close monitoring.

5 high priority 16 medium 21 total filings